57 Series B medtech investors

Top 5 Series B medtech investors, ranked by recent fund activity

Among firms with a published profile and a dated fund or deal in the last 24 months. The rule: Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stage focus (15: all of it when Series B is the only stage the firm states, split evenly when it states more), size of the fund on file on a log scale (15) and completeness of the public record (10). Stage focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns. The same rule orders the whole list; it is repeated in the method box.

1. BGF

   Type: VC firm · HQ: United Kingdom · Stages: Seed, Series A, Series B, Growth · Focus: Medtech, Healthtech, Edtech, Developer Tools · Latest activity: Portfolio news, Oct 2026 · Fund size or assets: £3.0B (own site)

   Portfolio news dated Oct 2026; £3.0B on file (own site); 40% of its observed portfolio is medtech and medical devices; backs seed, Series A, Series B; 8 named decision-makers on file.

2. Claritas Signal Partners

   Type: VC firm · HQ: Nashville, TN · Stages: Seed, Series A, Series B, Growth · Focus: Medtech, Healthtech, AI, Media · Latest activity: New deal, Aug 2026 · Fund size on file: $14M (SEC Form D, 2021)

   Dated new deal in Aug 2026; $14M fund on file (SEC Form D, 2021); 70% of its observed portfolio is medtech and medical devices; backs seed, Series A, Series B; 8 named decision-makers on file.

3. Parkwalk Advisors

   Type: SEIS/EIS fund · HQ: London, United Kingdom · Stages: Seed, Series A, Series B, Growth · Focus: Medtech, Healthtech, AI, Industrial Tech · Latest activity: New fund, Sep 2026 · Fund size or assets: £500M (own site)

   Latest fund filing dated Sep 2026; £500M on file (own site); 33% of its observed portfolio is medtech and medical devices; backs seed, Series A, Series B; 8 named decision-makers on file.

4. HBM Partners

   Type: Fund manager · HQ: Zug, Switzerland · Stages: Series A, Series B, Growth, Late stage · Focus: Medtech, Healthtech, Biotech · Latest activity: Portfolio news, Oct 2026 · Fund size or assets: $2.8B (own site)

   Portfolio news dated Oct 2026; $2.8B on file (own site); states medtech and medical devices as a focus; backs Series A, Series B, growth-stage; 1 named decision-maker on file.

5. Andera Partners

   Type: Fund manager · HQ: Paris, France · Stages: Seed, Series A, Series B, Growth · Focus: Medtech, Biotech, Healthtech, Generalist · Latest activity: Portfolio news, Sep 2026 · Fund size or assets: €6.0B (own site)

   Portfolio news dated Sep 2026; €6.0B on file (own site); states medtech and medical devices as a focus; backs seed, Series A, Series B.

First 25 of 57 Series B medtech investors

You are seeing 25 of 57. The full list adds 32 more investors and 296 named decision-makers.

How these 57 break down

Questions

Not sure this is the right list? Describe your raise in the investor matching tool and get a shortlist. The link opens it set to medtech and medical devices and Series B. Guide: how many investors to pitch. Markdown version of this page.